Aging
Navigate
Submit an Article
Research Paper|Volume 14, Issue 8|pp. 3597–3606
Synergistic blocking of RAS downstream signaling and epigenetic pathway in KRAS mutant pancreatic cancer
Back to articleFigure 2(2 of 4)
100%
Figure 2
Figure 2.The BET inhibitor JQ1 suppresses KRAS mutant pancreatic cancer cells. (A) The structure of the BET inhibitor JQ1. (B) Fitting curve of cytostatic responses illustrated a decreasing concentration gradient of JQ1 treated with 7 KRAS mutant pancreatic cancer cell lines (AsPC-1, MIA PaCa-2, PANC-1, HuP-T4, HuP-T3, PSN1, and CFPAC-1).
Figure 2 — Synergistic blocking of RAS downstream signaling and epigenetic pathway in KRAS mutant pancreatic cancer | Aging